IRLAB Therapeutics (Sweden) Analysis
| IRLAB-A Stock | SEK 3.35 0.16 4.56% |
IRLAB Therapeutics AB is overvalued with Real Value of 3.22 and Hype Value of 3.21. The main objective of IRLAB Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what IRLAB Therapeutics AB is worth, separate from its market price. There are two main types of IRLAB Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect IRLAB Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of IRLAB Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The IRLAB Therapeutics stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and IRLAB Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
IRLAB |
IRLAB Stock Analysis Notes
About 39.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. IRLAB Therapeutics had 5:1 split on the 28th of May 2019. IRLAB Therapeutics AB operates as a drug discovery and development company that provides drugs in the field of neurological and neuropsychiatric disorders. Its pipeline candidates include IRL790, a psychomotor stabilizer for the treatment of L-dopa induced dyskinesias in Parkinsons disease and Parkinson disease psychosis IRL752, a cortical enhancer for the treatment of Parkinson disease dementia and behavioral and psychological symptoms of dementia IRL626, a fast-off D2 antagonist for use in the treatment of schizophrenia P001, a cortical enhancer program for the treatment of attention disorders and IRL448IRL555, a followup Parkinsons disease program. IRLAB Therapeutics is traded on Stockholm Stock Exchange in Sweden. To learn more about IRLAB Therapeutics AB call the company at 46 3 17 57 38 00 or check out https://www.irlab.se.IRLAB Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. IRLAB Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding IRLAB Therapeutics AB or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| IRLAB Therapeutics generated a negative expected return over the last 90 days | |
| IRLAB Therapeutics has high historical volatility and very poor performance | |
| About 39.0% of the company shares are held by company insiders |
IRLAB Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 525.71 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IRLAB Therapeutics's market, we take the total number of its shares issued and multiply it by IRLAB Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.IRLAB Profitablity
IRLAB Therapeutics' profitability indicators refer to fundamental financial ratios that showcase IRLAB Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, IRLAB Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, IRLAB Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of IRLAB Therapeutics' profitability requires more research than a typical breakdown of IRLAB Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.68) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.68. Technical Drivers
As of the 20th of July, IRLAB Therapeutics retains the Market Risk Adjusted Performance of 2.33, coefficient of variation of (621.31), and Risk Adjusted Performance of (0.14). IRLAB Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.IRLAB Therapeutics Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of IRLAB Therapeutics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out IRLAB Therapeutics short-term fluctuations and highlight longer-term trends or cycles.
IRLAB Therapeutics Outstanding Bonds
IRLAB Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. IRLAB Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IRLAB bonds can be classified according to their maturity, which is the date when IRLAB Therapeutics AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
IRLAB Therapeutics Predictive Daily Indicators
IRLAB Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of IRLAB Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
IRLAB Therapeutics Forecast Models
IRLAB Therapeutics' time-series forecasting models are one of many IRLAB Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IRLAB Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About IRLAB Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how IRLAB Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IRLAB shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as IRLAB Therapeutics. By using and applying IRLAB Stock analysis, traders can create a robust methodology for identifying IRLAB entry and exit points for their positions.
IRLAB Therapeutics AB operates as a drug discovery and development company that provides drugs in the field of neurological and neuropsychiatric disorders. Its pipeline candidates include IRL790, a psychomotor stabilizer for the treatment of L-dopa induced dyskinesias in Parkinsons disease and Parkinson disease psychosis IRL752, a cortical enhancer for the treatment of Parkinson disease dementia and behavioral and psychological symptoms of dementia IRL626, a fast-off D2 antagonist for use in the treatment of schizophrenia P001, a cortical enhancer program for the treatment of attention disorders and IRL448IRL555, a followup Parkinsons disease program. IRLAB Therapeutics is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding IRLAB Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Complementary Tools for IRLAB Stock analysis
When running IRLAB Therapeutics' price analysis, check to measure IRLAB Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRLAB Therapeutics is operating at the current time. Most of IRLAB Therapeutics' value examination focuses on studying past and present price action to predict the probability of IRLAB Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRLAB Therapeutics' price. Additionally, you may evaluate how the addition of IRLAB Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |